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Abstract
Acting as fuel combustion catalysts to increase fuel economy, cerium dioxide (ceria, CeO2) nanoparticles have been used in
Europe as diesel fuel additives (EnviroxTM). We attempted to examine the effects of particles emitted from a diesel engine
burning either diesel (diesel exhaust particles, DEP) or diesel doped with various concentrations of CeO2 (DEP-Env) on innate
immune responses in THP-1 and primary human peripheral blood mononuclear cells (PBMC). Batches of DEP and DEP-Env
were obtained on three separate occasions using identical collection and extraction protocols with the aim of determining
the reproducibility of particles generated at different times. However, we observed significant differences in size and surface
charge (zeta potential) of the DEP and DEP-Env across the three batches. We also observed that exposure of THP-1 cells and
PBMC to identical concentrations of DEP and DEP-Env from the three batches resulted in statistically significant differences
in bioreactivity as determined by IL-1b, TNF-a, IL-6, IFN-c, and IL-12p40 mRNA (by qRT-PCR) and protein expression (by
ELISPOT assays). Importantly, bioreactivity was noted in very tight ranges of DEP size (60 to 120 nm) and zeta potential (237
to 241 mV). Thus, these physical properties of DEP and DEP-Env were found to be the primary determinants of the
bioreactivity measured in this study. Our findings also point to the potential risk of over- or under- estimation of expected
bioreactivity effects (and by inference of public health risks) from bulk DEP use without taking into account potential batch-
to-batch variations in physical (and possibly chemical) properties.
Citation: Sarkar S, Zhang L, Subramaniam P, Lee K-B, Garfunkel E, et al. (2014) Variability in Bioreactivity Linked to Changes in Size and Zeta Potential of Diesel
Exhaust Particles in Human Immune Cells. PLoS ONE 9(5): e97304. doi:10.1371/journal.pone.0097304
Editor: Sidney Arthur Simon, Duke University Medical Center, United States of America
Received October 31, 2013; Accepted April 17, 2014; Published May 13, 2014
Copyright:  2014 Sarkar et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Funding Sources: Joint US – UK Research Program: Environmental Behavior, Bioavailability and Effects of Manufactured Nanomaterials (EPA-G2008-
STRAT-R1) and NIEHS R01ES020382-02 (S.Schwander). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: schwansk@sph.rutgers.edu
Introduction
Diesel exhaust particles (DEP) can contribute up to 40% of the
total mass of urban ambient aerosolized particulate matter (PM),
and therefore, are of major concern for public health as well as
environmental monitoring agencies and the automobile industry
[1]. Large fractions of the particles comprising the total DEP mass
are in an aerodynamic diameter range of,2.5 mm (PM2.5) [2] and
can reach pulmonary alveolar spaces. Inhalation of PM2.5 results
in physical interactions between the particles themselves on the
one hand and the particles and lining fluid as well as the cellular
immune system of the respiratory tract on the other hand.
Particularly, the ultrafine components of the PM2.5 are sufficiently
small (,100 nm) to cross the lining fluid and respiratory epithelial
cell layers and, thus, could potentially gain access to the systemic
circulation, i.e. the blood stream, resulting in adverse health effects
in remote organs [3–8].
DEP, a model for primary PM, have been studied extensively
for their toxicity, bioreactivity, and health effects in experimental
and observational studies [9]. DEP have also been shown to
induce toxicity both in vitro and in vivo in animals as well as in
humans [10–18]. In addition, DEP are known to alter the allergic
disposition and host immune responses to bacteria by inducing a
switch from a baseline Th1 to a Th2 cytokine profile [19,20], and
by reducing the capacity of mice co-exposed to DEP and
Mycobacterium tuberculosis (M.tb) [21] or Listeria monocytogenes infection
[22,23] to control the bacterial growth in their lungs.
Attempts to reduce the environmental impact of DEP include
innovations in engine design technologies, improvements of diesel
fuels, and the use of fuel additives [24,25]. Recently, cerium
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dioxide (CeO2) nanoparticles have been used as a fuel-borne
catalyst in Europe and elsewhere [24,25]. The primary motivation
for using nanotechnology-based diesel additives like CeO2 is to
increase the engine combustion efficiency and thereby saving fuel
(www.energenics.co/uk/category/case-studies/). However, it re-
mains to be determined whether the addition of CeO2 nanopar-
ticles, which can lead to changes in physicochemical properties of
the DEP [26], alters the toxicity and bioreactivity of DEP [9]. The
original goal of the current study was to compare the effects of
particles (DEP) from a diesel engine (electrical power generator)
combusting a regular diesel fuel with particles (DEP-Env) from the
same engine combusting the diesel fuel with a commercial CeO2
diesel additive (Envirox, www.energenics.co/uk/category/case-
studies/). Furthermore, since one effect of CeO2 diesel additive
Envirox to the diesel fuel is the alteration of particle size, we
hypothesized that CeO2 addition would have an impact on
bioreactivity. Immunocytotoxicity and bioreactivity of DEP and
DEP-Env were assessed in THP-1 cells, a human monocytic
leukemia cell line and primary human peripheral blood mononu-
clear cells (PBMC). Furthermore, to assess effects of DEP and
DEP-Env on pathogen-specific functional immune responses, cells
were co-exposed to DEP or DEP-Env and the respiratory
pathogen M.tb. During the course of the study, we used DEP
and DEP-Env from three independent batches that were collected,
stored, and extracted at different times following the same
protocols. Surprisingly, we observed large batch-to-batch varia-
tions in physical properties (size and surface charge) of as-exposed
DEP and DEP-Env for the same fuel-Envirox combinations as
well as in the DEP and DEP-Env-induced bioreactivity and
functional immune response profiles. These batch-to-batch vari-
ations hampered our ability to address our original goal of
assessing the effect of the presence of CeO2/Envirox at different
concentrations in diesel fuel. However, an important and crucial
discovery was that across the three collections (batches), a marked
correlation between physical properties of DEP and DEP-Env (i.e.
size and zeta potential) and bioreactivity (induction of an immune
response) was observed.
These novel observations indicate that variability in the physical
characteristics of DEP, which may have been collected and
processed using different protocols across different studies, are
likely to produce inconsistent findings. The current work has
important implications in particular for experimental studies in
biological systems that often examine aged bulk DEP without prior
knowledge of its physicochemical properties.
Methods
Collection of Diesel Exhaust Particles (DEP)
All DEP generation and batch collections were conducted in the
Controlled Environmental Facility (CEF) at the Environmental
and Occupational Health Sciences Institute (EOHSI) of Rutgers
University. The diesel exhaust generation system is an integrated
part of the CEF. The diesel exhaust generation system consists of a
diesel generator (Model YDG 5500E, Yanmar Inc.) and a stainless
steel piping delivery and dilution system. The generator was
operated at 100% load using heaters. The system used a series of
control valves to adjust the amount of diesel exhaust between the
exhaust stack and the CEF to maintain the desired concentration
of particles. The DEP was collected after the exhaust was diluted
with filtered CEF intake air at room temperature.
DEP from a regular diesel fuel and those (DEP-Env) from the
fuel doped with Envirox (a diesel additive containing CeO2
nanoparticles) were generated and collected at three different time
points in 2012 (batch #1, #2 and #3). Envirox was added to the
regular diesel fuel at concentrations of 0.1, 1, and 10-fold the
manufacturer-recommended doping concentrations (hereafter
denoted DEP-0.1x, DEP-1.0x, DEP-10x), corresponding to
CeO2 concentrations in the fuel of 0.9 mg/ml, 9.0 mg/ml, and
90 mg/ml, respectively. The diesel fuel was number 2 diesel (ultra-
low sulfur diesel) that was available at any gas station in New
Jersey during the DEP collection period in 2012. More detailed
characteristics of the fuel, Envirox, the engine, and the DEP
generation system can be found in another publication [26].
The exhaust diesel particles were collected onto 37 mm Teflon
filters (Pall Corp.-Life Sciences, Ann Arbor, Michigan 48103,
USA) using an air sampling pump at a flow rate of 10L/min for
3 hours. Before and after the sample collection, the filters were
placed for at least 24 hours in a climate-controlled weighing room
and then weighed using a high-sensitivity microbalance (Mettler
Model XP6 with a sensitivity of 1 mg) under static-charge-free
conditions. After collection, filters were individually placed in Petri
dishes, wrapped with aluminum foil to avoid light exposure, and
then placed in a -20uC freezer. Samples were collected on 4
different days between January 16 and February 16, 2012 for
Batch 1 series (0X, 0.1X, 1X, and 10X), on March 26, 2012 for
Batch 2 series, and on May 22, 2012 for Batch 3 series.
Preparation of DEP Suspension for In vitro Studies
DEP and DEP-Env filters were immersed into 10 mL of HPLC-
grade water (Sigma Co.) in a glass vial. To avoid microbial
contamination, the glass vials were baked in an oven at 120uC
overnight prior to use. The vial was then placed into an ultrasonic
water bath (Model FS9, 55W, 43 KHZ, Fisher Scientific Co.
USA) and sonicated intermittently over a period of 5 days for a
cumulative duration of 48 hours. At the completion of filter
extraction, filters were taken out of the vial, and the vials
containing DEP or DEP-Env water suspensions were stored in a
4uC refrigerator until further use. After extraction filters were left
to dry at room temperature before being weighed in the same
weighing room. The difference between filter mass before and
after the extraction was used to determine the concentration of the
DEP or DEP-Env suspensions. The extraction efficiency (the
fraction of particles extracted off the filter in the total particle mass
collected on the filter) ranged from 91 to 95%. Prior to use in cell
exposure studies, the vials containing DEP or DEP-Env suspen-
sions were sonicated for 5 minutes to ensure uniform dispersion,
then aliquots were taken and added to the culture medium at
desired concentrations (doses).
Characterization of DEPs for Size and Surface Charge
The hydrodynamic size and zeta potential of DEP were
measured using the Zetasizer (ZS Nano) dynamic light scattering
instrument (Malvern Instruments, Malvern, UK) at 25uC with a
detection angle of 90u. DEP and DEP-Env samples were sonicated
for 5 minutes using a bath sonicator (Branson Electronics) and
then diluted to a final concentration of 50 mg/mL in phosphate-
buffered saline buffer (pH=7.4). The number-averaged size and
zeta potential values of the samples were then measured using the
Zetasizer and averaged over 11 runs (replicates) for size
measurements and 13 runs for the zeta potential measurements.
Endotoxin Analysis
DEP and DEP-Env samples from batch #1-3 were tested for
endotoxin contamination by kinetic turbidity Limulus Amoebo-
cyte Lysate [LAL reagent, Associates of Cape Cod (ACC, East
Falmouth, MA), T0051)] assay. DEP and DEP-Env samples were
diluted with LAL reagent water (ACC, WP0501) to a final
concentration of 1.0 mg/mL and the endotoxin concentration was
DEP Batch-to-Batch Variation in Bioreactivity
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analyzed on the PyrosFlex instrument. E.coli lipopolysaccharide
supplied by ACC was reconstituted in LAL reagent water and
used for the generation of standard curve. Assay internal controls
and standards were run with each analysis and were within the
USP and FDA requirements of LAL tests [27].
Study Subjects
Approval to perform this study, collect personal health
information, and perform venipunctures was given by the
Institutional Review Boards of the University of Medicine and
Dentistry of New Jersey (UMDNJ) in Newark and New Brunswick
(IRB protocol number 0220100112). After obtaining the written
informed consent, peripheral venous blood was obtained by
venipuncture from three healthy donors (two female and one male,
mean age 45.6 [min. 26, max. 56] years).
Cell Cultures
Preparation of THP-1. THP-1 cells (Cat. No. TIB-202)
were obtained from American Type Culture Collection (ATCC)
and cultured in RPMI1640 supplemented with Penicillin/Strep-
tomycin/Glutamine and 10% fetal bovine serum (Hyclone
Laboratories, Inc. Logan, Utah) and 0.05 mM 2-mercaptoethanol.
Cells were maintained at 37uC in humidified 5% CO2 environ-
ment. Cells were passaged every 3–4 days. Cells were maintained
for 4–6 weeks in culture and then discarded.
Preparation of Peripheral Blood Mononuclear Cells
(PBMC). PBMC were prepared from whole heparinized venous
blood by Ficoll gradient centrifugation [28]. Whole blood was
diluted 1:1 with L-glutamine-supplemented RPMI 1640 medium
and centrifuged over a Ficoll-Paque density gradient (1200 rpm,
45 min, and 21uC). Following removal from the interface with
Pasteur pipettes, PBMC were washed two times in RPMI 1640,
and then resuspended in culture medium (RPMI1640 + L-
glutamine + 10% pooled human AB serum). PBMC were then
counted, and adjusted to required concentrations. The viability of
PBMC was consistently between 98–100% by trypan blue
exclusion.
Preparation of DEP and DEP-Env for in vitro Exposure
Studies
To assess the effects of DEP and DEP-Env on cell viability and
bioreactivity, DEP and DEP-Env (DEP-0.1x, DEP-1.0x, DEP-10x)
samples from three independent collections were diluted in
complete culture media (RPMI1640 supplemented with Penicil-
lin/Streptomycin/L-Glutamine and 10% pooled human AB
serum) following sonication in Branson 3510 water bath sonicator
for 2 minutes.
Viability Assays
Cell proliferation, as a marker of viability, was assessed by Cell
Titer 96 Aqueous One Solution Cell Proliferation Assay [MTS, (3-
(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfo-
phenyl)-2H-tetrazolium) catalogue number G3580, Promega,
Madison, WI]. PBMC (100,000/well) were incubated with 0, 1,
10 and 50 mg/mL of DEP and DEP-Env in 96-well tissue culture
plates in a total volume of 200 ml per well at 37uC in a humidified
CO2 environment for 4 and 24 hours. Equivalent amounts of
HPLC water (used for preparing DEP and DEP-Env suspensions)
were used to dilute DEP and DEP-0.1x, DEP-1.0x, DEP-10x
particles to account for any effect water may have on cell viability.
Following the incubation period, cells were centrifuged at 2506g
for 4 minutes and culture supernatants removed. Cell Titer 96
Aqueous One Solution was diluted 1:6 with phenol red-free
RPMI1640 + 5% PHS + P/S/G and added to the cells in 96-well
culture plates. After a 1-hour incubation at 37uC in a humidified
CO2 environment (incubator), optical density (OD) was recorded
at 493 nm. The percentage of viable cells was calculated as the
ratio of the OD of stimulated PBMC (after the subtraction of
background) to the OD of unexposed PBMC (after the subtraction
of background)6 100.
In addition, effects of DEP and DEP-Env (DEP-0.1x, DEP-1.0x,
DEP-10x) on the viability of PBMC were measured by trypan blue
exclusion assay as follows. PBMC (16106/well) were plated out in
24-well cell culture dishes and incubated with 0, 10 and 50 mg/mL
of DEP and DEP-Env samples, respectively, in a total volume of
1 mL per well for 4 and 24 hours at 37uC in a humidified CO2
environment. Cells were diluted 1:1 with trypan blue dye (Life
technologies, Grand Island, NY, Cat. No. 15250061) and counted
after 4 and 24 hours incubation with DEP and DEP-Env samples
with a hemocytometer at a magnification of 4006under a bright
field microscope. Numbers of viable and dead (blue) cells were
recorded. The percentage of cell death was recorded as the ratio of
number of dead cells (blue) to the total number of cells6 100.
Quantitation of Cytokine Responses
Frequencies of IFN-c, TNF-a, IL-1b-producing cells were
enumerated with ELISPOT assays as described before [18].
Briefly, 200,000, 100,000 and 20,000 PBMC were incubated with
1 and 10 mg/mL of DEP and DEP-Env samples for IFN-c, IL-1b
and TNF-a, respectively, for 24 hours as recommended by the
manufacturer. Following washing with PBS and PBS/0.5%
Tween20, appropriate detection antibodies were added to the
plates and incubated for 1 hour at 37uC in a humidified CO2
environment for IL-1b and overnight at 4uC for IFN-c and TNF-
a. Following washing with PBS/0.5% Tween20, spots were
visualized with peroxide–conjugated streptavidin, HRP and
chromogen 1% 3-amino-carbamizole. After washing, plates were
developed and frequencies of cytokine-producing cells were
analyzed by computerized image analysis using a Series 5 Macro
reader with software 6.4.82 (C.T.L, Cleveland, OH) as described
previously [18].
Quantitative RT-PCR to determine Cytokine mRNA
Expression
To assess the abundance of mRNAs encoding TNFa, IL1b, IL6,
and IL12p40, PBMC (26106) were incubated with 1 and 10 mg/mL
of DEP or DEP-Env samples for 4 hours at 37uC in a humidified
CO2 environment. TNF-a, IL-1b, IL-6, and IL-12p40 are
proinflammatory cytokines with important functions in protective
antimycobacterial human host immunity. Total RNA was extracted
from stimulated cells with RNeasy mini columns (Qiagen) as
described [18]. Briefly, 250 ng of total RNA was transcribed into
cDNA with Taqman reverse transcription reagents (applied
Biosystems). cDNA was analyzed by qRT-PCR to determine the
abundance of mRNAs encoding TNFa, IL1b, IL6, and IL12p40. The
following primer sets were used for qRT-PCR, TNFa forward:
GTGCTTGTTCCTCAGCCTCTT, TNFa reverse: ATGGGC-
TACAGGCTTGTCATC; IL1b forward: GAAGCTGATGGCC-
CTAAACAG, IL1b reverse: AGCATCTTCCTCAGCTTGTCC;
IL6 forward: AGACAGCCACTCACCTCTTCA, IL6 reverse:
CACCAGGCAAGTCTCCTCATT; IL12p40 forward: GGTG-
GCTGACGACAATCAGTA, IL12p40 reverse: TCCTTGTTG-
TCCCCTCTGACT.
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Bioreactivity Assessments
For in vitro cell exposure (bioreactivity studies), DEP, DEP-0.1x,
DEP-1.0x, and DEP-10x were suspended into cell culture media
by sonication of a stock suspension as described above (2 minutes
in water bath sonicator). In vitro cell exposure experiments (viability
and bioreactivity studies) were performed with DEP, DEP-0.1x,
DEP-1.0x, and DEP-10x at concentrations ranging from 0 to
50 mg/mL.
M.tb Exposure
PBMC were infected with avirulent M.tb (ATCC strain H37Ra,
Cat. No. 25177) at a multiplicity of infection (MOI) of 10. MOI is
the ratio of M.tb bacteria to blood monocytes within the PBMC.
Statistical Methods
Mixed linear models were used to assess the association between
either particle size or zeta potential and cytokine mRNA
expression (IL6, TNFa, IL12p40 and IL1b). A random effect for
donor ID was included in order to account for potential
correlation between observations from the same donor. Because
there were a few particle sizes that were virtually identical, particle
sizes were grouped into bins of 10 nanometers (50–59.9, 60–69.9,
etc.). Values for zeta potential were distinct and not collapsed.
Particle size and zeta potential were treated as categorical
variables within the linear model. An F-test was used to determine
whether particle size or zeta potential had any association with the
log-transformed cytokine values, followed by all pairwise compar-
isons between particle sizes or zeta potentials. Log-transformations
were applied to the outcomes in order to stabilize the variance and
normalize the distribution of cytokine expression. Separate
analyses were conducted for mRNA expressions in response to 1
and 10 mg/mL exposures. In order to assess whether the additive
effect was the same across collections, we used mixed linear models
that included main effects for batch ID, sample ID as well as the
cross-product. Sample ID was given values of 1, 2, 3 and 4 and
included as a continuous variable. Specifically, an F-test of the
cross-product was used to assess the hypothesis of interest. Again,
random effects for donor ID accounted for correlations between
cytokine levels from the same donors. The effect of each dose of
additive (DEP-Env) was assessed individually and in aggregate
within each collection. For these analyses, mixed linear models
included presence of each level of additive (DEP-Env) as a
categorical variable (rather than continuous), using contrasts to
compare the cytokine responses following exposure to DEP-Env at
each level of additive to cytokine responses following exposure
with no additive.
Results and Discussion
Physical Properties of DEP and DEP-Env
Hydrodynamic sizes and zeta potentials of DEP and DEP-Env
are shown in Tables 1 and 2, respectively. DEP-0.1x appeared to
have the smallest mean diameters in all the three batches. The
mean particle diameters for batch #3 increased with increasing
Envirox concentrations and were markedly different from those of
batches #1 and #2. Within the same fuel-Envirox combination
(0.1x, 1x, and 10x), large batch-to-batch variations were found,
especially between batch #3 and batches #1 and #2. Batch-to-
batch variations were also observed in zeta-potential.
Although identical collection and extraction protocols were
followed, the three batches of DEP and DEP-Env were collected in
different months and extracted after different storage durations on
the filters. Variations in engine combustion on different collection
dates may have contributed to variations in physicochemical
properties of as-collected DEP and DEP-Env. In addition, a longer
duration of filter storage may have increased agglomeration of
particles and resulted in loss of a larger amount of the more
volatile components of DEP or DEP-Env. We set out to assess the
origins of these variations in DEP properties using the existing data
but our evaluations were inconclusive. Exploring the reasons for
combustion variability was beyond the scope of this work but are a
topic for further investigation.
Table 1. Size of DEP and DEP-Env from Batches # 1-3.
Batch # DEP-0 DEP-0.1x DEP-1x DEP-10x
1 143.2617.9 57.768.7* 74.9613.5* 97.9615.1
2 104.5611.9 74.469.0 85.7610.0 99.566.2
3 123.2614.3 120614.8 153.3619.7 278.4656**
The hydrodynamic size DEP and DEP-Env from batch # 1, 2 and 3 was measured as described in METHODS. Mean particle diameter (nm) 6 standard errors from 11
replicates for each sample are listed above. Batch #1 * p,0.003 relative to DEP-0. Batch #3 ** p,0.01 relative to DEP-0 (2-tailed unpaired t-test with 95% confidence
level).
doi:10.1371/journal.pone.0097304.t001
Table 2. Zeta potential (mV) of DEP and DEP-Env from Batches # 1-3.
Batch # DEP-0 DEP-0.1x DEP-1x DEP-10x
1 235.962.1 236.762.0 239.462.1 237.461.8
2 24161.9 238.462.1 237.562.3 231.362.0
3 24462.3 24862.5 24162.5 227.562.0
The zeta potential of DEP and DEP-Env from batch # 1, 2 and 3 was measured as described in METHODS. Mean particle zeta potential (mV) 6 standard errors from 12
replicates for each sample are listed above.
Batch #2 * p,0.002 relative to DEP-0. Batch #3 ** p,0.0001 relative to DEP-0 (2-tailed unpaired t-test with 95% confidence level).
doi:10.1371/journal.pone.0097304.t002
DEP Batch-to-Batch Variation in Bioreactivity
PLOS ONE | www.plosone.org 4 May 2014 | Volume 9 | Issue 5 | e97304
Effect of DEP and DEP-Env Exposure on Viability of PBMC
Cellular toxicity in response to exposure to DEP and DEP-Env
from batches # 1-3 was evaluated in human PBMC by MTS
assay. PBMC were exposed to DEP, DEP-0.1x, DEP-1.0x, and
DEP-10x at concentrations of 0, 1, 10 and 50 mg/mL for 4
(Figure 1A) and 24 hours (Figure 1B). These time points reflect the
cell culture exposure durations for the assessments of cytokine
mRNA and protein expression, respectively. An increase of
metabolic activity/viability relative to the unexposed PBMC was
observed in PBMC exposed to 50 mg/mL DEP and DEP-Env
samples for 4 hours (Figure 1A). After 24 hours, PBMC exposed
to 50 mg/mL DEP-Env-1x and DEP-Env-10x from batches #1-3
showed the highest increase in metabolic activity (Figure 1B) as
seen at the 4-hour time point. Thus, none of the DEP and DEP-
Env samples had any significant cytotoxic effect on PBMC at 4
and 24 hours. However, we cannot ascertain whether increased
metabolic activity in PBMC exposed to $ 10 mg/mL of particles
relative to unexposed PBMC reflects a stimulation-induced
increase in cell numbers. In addition, we cannot rule out the
possibility that DEP and DEP-Env themselves contributed to
increased OD measurements (a measure of increased metabolic
activity) at the highest (50 mg/mL) concentration. To validate the
results of MTS assays, we assessed the cytotoxicity of DEP and
DEP-Env samples on PBMC with trypan blue exclusion assay
(Figure 1C and 1D).
PBMC were exposed to DEP, DEP-1.0x, and DEP-10x from
batch #1-3 at concentrations of 0, 10 and 50 mg/mL for 4
(Figure 1C) and 24 hours (Figure 1D). The percentage of viable
cells was calculated as the ratio of live cells to the total number of
cells (live and blue dead cells)6 100. No decrease of viable cell
numbers was observed in PBMC exposed to DEP and DEP-Env
samples from batch #1-3 for 4 hours relative to unexposed
PBMC. However, a decrease in the number of viable cells (25–
50%) was observed in cells exposed to 50 mg/mL of DEP-1x and
DEP-10x samples from batch #1 and to DEP-1x from batch #2
for 24 hours (Figure 1D). In addition, a slight decrease (,20%) in
viability of PBMC was noted following DEP and DEP-1x
(batch#1) as well as DEP and DEP1x (batch#2) exposures in
Trypan blue assays at 24 hours. No such decrease of viability was
observed in MTS assays. Taken together, these results indicate
that exposure to 10 mg/mL of DEP, DEP-0.1x, DEP-1.0x and
DEP-10x from all three batches at 4 and 24 hours did not induce
significant cell death. Based on these results, we subsequently
exposed PBMC to DEP and DEP-Env samples at 1 and 10 mg/
mL concentrations to examine cytokine protein and mRNA
expression profiles.
Figure 1. Effect of DEP and DEP-Env Exposure on the Viability of PBMC. Human PBMC (100, 000/well) from a healthy donor were exposed
to indicated amounts of DEP, DEP-0.1x, DEP-1.0x, and DEP-10x from three independent batches for 4 (A) and 24 hours (B). Metabolic activity of cells
(proportional to the number of viable cells) was evaluated by MTS assay (A, B). PBMC exposed to no particles served as controls. Percent (%) viability
of PBMC exposed to DEP and DEP-ENV samples was expressed as the ratio of OD of samples to the OD of unexposed control PBMC x 100. Dashed
horizontal lines indicate viability of unexposed PBMC (0 mg, control). Human PBMC (106/well) from a healthy donor were exposed to indicated
amounts of DEP, DEP-0.1x, DEP-1.0x, and DEP-10x from three batches for 4 (C) and 24 hours (D). Numbers of live PBMC were counted with trypan
blue and the percentage of viable trypan blue-excluding cells expressed as the ratio of live cells and the total number of cells (live and dead blue
cells) x 100. Dashed horizontal lines indicate viability of unexposed PBMC (0 mg, control).
doi:10.1371/journal.pone.0097304.g001
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Effect of DEP and DEP-Env on Immune Cell Bioreactivity
IL1b, TNFa, IL6 and IL12p40 mRNA Expression. In a
first set of experiments, THP-1 cells were exposed to DEP, DEP-
0.1x, DEP-1.0x, and DEP-10x at final concentrations of 0, 1 and
10 mg/mL, and the levels of mRNA encoding IL1b, TNFa, IL6 and
IL12p40 were compared by qRT-PCR (Figure 2, panels A, B, C
and D). Exposure of THP-1 cells to DEP, DEP-0.1x, DEP-1.0x,
and DEP-10x from batch #1 resulted in an increase in mRNA
expression for all cytokines examined as the proportions of
Envirox relative to DEP increased in DEP-Env samples (DEP-
Figure 2. Effects of DEP and DEP-Env Exposure on Cytokine mRNA and Protein Expression in THP-1 Cells. THP-1 cells were exposed to
indicated concentrations of DEP, DEP-0.1x, DEP-1.0x, and DEP-10x from three independent batches (#1-3) for 4 hours. The abundance of mRNAs
encoding IL1b, TNFa, IL6 and IL12p40 was examined by real-time PCR assays (A, B, C, and D). Alterations of mRNA levels in THP-1 cells exposed to
DEP, DEP-0.1x, DEP-1.0x, and DEP-10x samples are shown as fold changes (y-axes) relative to unexposed (control) THP-1 cells cultured in complete
media. THP-1 cells were exposed to indicated concentrations of DEP, DEP-0.1x, DEP-1.0x, and DEP-10x from three independent batches (#1-3) for
24 hours (E and F). Frequencies of IL-1b and TNF-a cytokine-producing THP-1 cells were assessed by ELISPOT assay. The y-axes represent frequencies
of cytokine-producing cells. To demonstrate the change in the expression profile of mRNAs encoding IL1b, TNFa, IL6 and IL12p40 and of IL-1b and
TNF-a-producing cells exposed to DEP and DEP-0.1x, DEP-1.0x, DEP-10x from batch #1-3, straight lines indicating the trends are inserted.
doi:10.1371/journal.pone.0097304.g002
Table 3. Endotoxin Concentrations in DEP and DEP-Env from Batch # 1-3.
Batch # DEP-0 DEP-0.1x DEP-1x DEP-10x
1 2.58 3.68 11.9 2.88
2 8.96 13.1 9.3 26.7
3 8.4 14.2 9.4 10.1
Endotoxin concentrations listed in endotoxin units (EU) per mL of particle suspension were assessed by Limulus amebocyte lysate (LAL) assay in DEP and DEP-Env
samples from batch #1, 2 and 3.
doi:10.1371/journal.pone.0097304.t003
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0.1x, DEP-1.0x, DEP-10x). Exposure of THP-1 cells to corre-
sponding concentrations of DEP, DEP-0.1x, DEP-1.0x, and DEP-
10x from batch #2, however, resulted in a decrease in mRNA
expression for all cytokines examined as the proportions of
Envirox increased in DEP-Env samples. In contrast to batches #1
and #2, exposure of THP-1 cells to DEP, DEP-0.1x, DEP-1.0x,
and DEP-10x from batch #3 resulted in barely detectable levels of
cytokine mRNA as seen in unexposed cells (Figure 2, panels A, B,
C and D).
IL-1b and TNF-a Protein Expression. To validate the
effects of DEP and DEP-Env samples on cytokine mRNA
expression, frequencies of THP-1 cells producing IL-1b and
TNF-a were assessed by ELISPOT assay in response to exposure
to DEP, DEP-0.1x, DEP-1.0x, and DEP-10x at 0, 1, 10 and
50 mg/mL final concentration (Figure 2E and 2F). As expected,
the IL-1b and TNF-a protein expression profiles (Figure 2E and
2F) in response to exposure to DEP, DEP-0.1x, DEP-1.0x, and
DEP-10x from batch #1-3 correlated with the corresponding IL1b
and TNFa mRNA expression profiles (Figure 2A and 2B).
Exposure to batch #1 DEP-1.0x and DEP-10x samples, appeared
to increase the frequency of IL-1b and TNF-a-producing THP-1
cells (relative to DEP) while exposure to batch #2 samples
appeared to decrease the frequencies of cytokine-producing THP-
1 cells following DEP-1.0x and DEP-10x exposure (relative to
Figure 3. Effects of DEP and DEP-Env Exposure on Cytokine mRNA Expression in Human PBMC. PBMC from healthy donors (n = 3) were
exposed to indicated concentrations of DEP, DEP-0.1x, DEP-1.0x, and DEP-10x from three independent batches (#1-3) in absence (A, C, E, and G) or
presence (B, D, F, and H) of M.tb H37Ra at a multiplicity of infection (ratio of M.tb bacteria to blood monocytes within the PBMC) of 10 for 4 hours.
The abundance of mRNAs encoding IL1b, TNFa, IL6 and IL12p40 was examined by real-time PCR assays as described before. Alterations of mRNA levels
in PBMC exposed to DEP and DEP-0.1x, DEP-1.0x, DEP-10x samples are shown as mean fold-changes 6 SD (y-axes) relative to unexposed (control)
PBMC cultured in complete media. To demonstrate the change in the expression profile of mRNAs encoding IL1b, TNFa, IL6 and IL12p40 in cells
exposed to DEP, DEP-0.1x, DEP-1.0x, and DEP-10x from batch #1-3, straight lines indicating the trends are inserted in the left panel.
doi:10.1371/journal.pone.0097304.g003
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DEP). Exposure of THP-1 cells to DEP-0.1x from either batch #1
or #2 did not appear to be significantly different from that of DEP
exposed THP-1 cells. Very few IL-1b (Figure 2E) and TNF-a-
producing (Figure 2F) THP-1 cells were observed following
exposure to batch #3 samples.
Endotoxin Levels in DEP and DEP-Env Samples
To rule out the possibility that DEP and DEP-Env-mediated
bioreactivity was due to endotoxin contamination, we measured
the amount of endotoxin in DEP and DEP-Env samples (Table 3).
The relatively low levels of endotoxin in DEP and DEP-Env
samples from batches #1-3 did not correlate with the bioreactivity
of the corresponding samples. Furthermore, previous studies of the
effects of endotoxin in these models indicated that this concen-
tration of endotoxin would have no effect. Therefore, observed
differences in the bioreactivity resulting from cell exposure to
batch#1-3 was unlikely due to the variation in endotoxin contents
in different samples.
Effects of DEP and DEP-Env on Pathogen-specific
Functional Immune Responses
To assess effects of DEP and DEP-Env on pathogen-specific
innate host immune responses, PBMC from three healthy adult
blood donors were exposed to DEP, DEP-0.1x, DEP-1.0x, and
DEP-10x alone (Figure 3, left panel) or simultaneously to whole
viable M.tb at a MOI of 10 (Figure 3, right panel). In these
experiments M.tb served as a public health-relevant pathogen
stimulus to examine whether antimicrobial responses of the PBMC
would be altered as a result of their simultaneous exposure to M.tb
and DEP, DEP-0.1x, DEP-1.0x, or DEP-10x. Similar to the
findings in THP-1 cells (Figures 2), following exposure to batch #1
samples, mRNA expression of all cytokines appeared to increase in
PBMC exposed to DEP-1.0x and DEP-10x relative to DEP-
exposed PBMC. In contrast, exposure to batch #2 samples,
mRNA expression of all cytokines appeared to decrease in PBMC
exposed to DEP-1.0x and DEP-10x relative to DEP-exposed
PBMC. PBMC exposed to the batch #3 samples had barely
detectable effects on mRNA expression levels for all cytokines
relative to unexposed PBMC (Figure 3, panels A, C, E, and G).
Figure 4. Effects of DEP and DEP-Env Exposure on Cytokine Expression in Human PBMC. PBMC from healthy donors (n = 3) were exposed
to indicated concentrations of DEP, DEP-0.1x, DEP-1.0x, and DEP-10x from three independent batches (#1-3) in absence (left panel) or presence (right
panel) of M.tb H37Ra at a multiplicity of infection of 10 (10 M.tb bacteria per blood monocyte within the PBMC) (0 mg/mL) for 24 hours. Frequencies
of IL-1b, TNF-a and IFN-c-producing PBMC were assessed by ELISPOT assay. Y-axes represent cytokine spot frequencies (numbers) of cytokine-
producing cells (mean 6 SD). To demonstrate the change in the expression profile of cytokine-producing cells exposed to DEP, DEP-0.1x, DEP-1.0x,
and DEP-10x from batches #1-3, straight lines indicating the trend are inserted.
doi:10.1371/journal.pone.0097304.g004
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Between-batch variability of DEP and DEP-Env samples was
apparent in bioreactivity of both the cell line (THP-1) and primary
(PBMC) immune cells.
PBMC simultaneously exposed to DEP or DEP-0.1x or DEP-
1.0x, or DEP-10x from batch #1-3 and M.tb MOI10 (Figure 3,
panels B, D, F, and H) did not follow the IL1b, TNFa, IL6 and
IL12p40 mRNA expression profiles observed for PBMC exposed
to DEP and DEP-Env samples alone. The variations in the
bioreactivity were less evident in M.tb-infected PBMC than in
uninfected PBMC. It is worth noting that the co-exposure of
PBMC to M.tb and DEP or DEP-Env samples led to the
expression of much higher levels of IL1b, TNFa, IL6 and
IL12p40 mRNA compared to PBMC exposed to DEP and DEP-
Env samples alone. This finding suggests that the strength of the
M.tb-induced mRNA fold-changes (MOI 10) probably masked the
modulatory effects of DEP, DEP-0.1x, DEP-1.0x, and DEP-10x
from batch # 1-3 seen without M.tb exposure (Figure 3, panels A,
C, E, and G) on the IL1b, TNFa, IL6 and IL12p40 mRNA
expression. Interestingly, when PBMC were stimulated with M.tb
at MOI1 between-batch differences in cytokine production (IFN-
c, IL-1b, TNF-a) were more clearly visible (data not shown).
In order to examine whether mRNA expression correlates with
protein expression, the frequencies of PBMC producing IL-1b,
TNF-a and IFN-c (cytokines important for human antimycobac-
terial immunity) were determined upon exposure of PBMC to the
DEP and DEP-Env samples in the absence or the presence of M.tb
MOI 10 by ELISPOT assay (Figure 4). Increases and decreases in
frequencies of IL-1b, TNF-a-producing PBMC (Figure 4, left
panel) followed the pattern that was observed in mRNA levels
(Figure 3, left panel) in response to exposure to DEP, DEP-0.1x,
DEP-1.0x, and DEP-10x samples from batch #1-3. While
exposure to DEP, DEP-0.1x, DEP-1.0x, and DEP-10x samples
from batch #3 resulted in low levels of cytokine protein
production, exposure to the batch #1 samples led to an increase
in the frequency of IL-1b, TNF-a and IFN-c-producing PBMC
with increasing proportion of Envirox (DEP-1.0x, DEP-10x)
relative to DEP-0.1x and DEP. Exposure to the batch #2
samples, however, tended to decrease the frequencies of cytokine-
producing PBMC following DEP-0.1x, DEP-1.0x and DEP-10x
exposure (relative to DEP) (Figure 4, left panel). Variations inM.tb-
induced IL-1b and TNF-a mRNA expression (Figure 3, right
panel) were not as well-defined as in the protein expression profile
(Figure 4, right panel) upon exposure to DEP and DEP-Env from
Figure 5. Effect of the Size of DEP and DEP-Env Particles on the Bioreactivity of Human PBMC. IL1b, TNFa, IL6, and IL12p40 mRNA fold-
changes (Y-axes) in PBMC (from 3 donors) shown in Figure 3 are plotted as a function of mean particle diameter in nanometers (x-axes). All particles
in the size range from 70 to 110 nm, with one exception (asterisk *), showed significantly higher bioreactivity (p,0.001) compared to the particles
below or above this size range.
doi:10.1371/journal.pone.0097304.g005
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batch#1-3. Upon exposure to the batch #1 and 3 samples, IFN-c
expression appeared to increase in PBMC exposed to DEP-1.0x
and DEP-10x relative to DEP-exposed PBMC. In contrast,
following exposure to the batch #2 samples, the expression of
IFN-c appeared to decrease in PBMC exposed to DEP-1.0x and
DEP-10x relative to DEP-exposed PBMC (Figure 4, right panel).
Links between Particle Physical Properties and
Bioreactivity
To examine whether differences in size or zeta potential may
have contributed to the observed differences in bioreactivity
following PBMC exposures to DEP, DEP-0.1x, DEP-1.0x, and
DEP-10x from batch #1-3, we plotted each of the bioreactivity
measures against particle size (Figure 5) and zeta potential
(Figure 6) using pooled data across all the DEP and DEP-Env
samples and across all the batches.
Interestingly, exposure to particles with mean diameters of 60 to
120 nm with one exception resulted in the highest levels of
bioreactivity as measured by mRNA fold-changes for IL1b, TNFa,
IL6 and IL12p40 relative to unexposed PBMC (Figure 5).
Similarly, high levels of bioreactivity with one exception (different
sample from sample that differed in size) were observed in samples
with mean particle charges in the range of 245 to 237 mV
(Figure 6). Statistical analysis employing mixed linear models to
assess associations between either particle size or zeta potential and
the expression of cytokine mRNA encoding IL6, IL1b, IL12p40
and TNFa revealed a significant association of cytokine expression
with particle size and zeta potential (see p-values in Figures 5 and
6). Interestingly, for both particle size and zeta potential there is a
critical point at which bioreactivity diminishes. It is possible, that
there is a particle size range at which the nature of cellular
interactions with particles changes, e.g. during particle uptake
processes that can change from passive to active. However, we did
not observe a clear relationship with endotoxin concentration.
Thus, size (diameter) and surface charge (zeta potential) appeared
to be the primary determinants of the differences observed in
bioreactivity from batches 1–3.
Monocytes in the PBMC are precursors of alveolar macro-
phages that take up, process and mediate toxicity and immune
effects of aerosolized particles in the lung milieu. As-exposed DEP
and DEP-Env with the relatively narrow size range (60 to 120 nm)
for which we observed bioreactivity, could cross through the
respiratory epithelium from the alveolar spaces in the lungs into
the systemic circulation, although in low quantities, this could be
important during chronic exposure or during significant air
pollution episodes [7]. Furthermore, the increased surface area
and surface reactivity of DEP in this size range could increase the
likelihood of cellular exposure to the soluble surface components of
Figure 6. Effect of Charge (Zeta Potential) of DEP and DEP-Env Particles on the Bioreactivity of Human PBMC. IL1b, TNFa, IL6, and
IL12p40 mRNA fold changes (y-axes) in PBMC (from n=3 donors) shown in Figure 3 are plotted here as a function of mean zeta potential in millivolt
(x-axes). All particles with zeta potentials from 237 to 241 mV, with one exception (asterisk *), showed significantly higher bioreactivity (p,0.001)
compared to the particles below or above this size range.
doi:10.1371/journal.pone.0097304.g006
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DEP, such as metals and polyaromatic hydrocarbons. This is
supported by previous findings that inhalation of diesel exhaust
generated in situ (containing DEPs in ,60 to 120 nm size range)
has led to extra-pulmonary and systemic effects such as oxidative
modifications of high-density lipoproteins (HDLs) in mice [9].
Statistical analysis revealed an association between the size and
zeta potential of as-exposed particles and bioreactivity, irrespective
of sample batch or DEP and DEP-Env. In all cases, the effects of
particle size and zeta potential were highly significantly associated
with cytokine expression (all p-values,0.0001, Figures 5 and 6).
Further, cytokine protein production and mRNA expression levels
differed significantly across all batches (all p-values ,0.0001) for
the 1 and 10 mg/mL DEP and DEP-Env exposures. For batches
#1 and #2, the slopes of the cytokine protein and mRNA
expressions from DEP, DEP-Env-0.1x, 1x and 10x exposures were
significantly different from 0 (unexposed cells) for all cytokines. For
batch #3, the slope was not significantly different from 0,
indicating no effect of the Envirox additions (Figure 3). Further,
the slopes following exposure to the particles from batch #1-3
were significantly different from one another (p-values for
differences overall p,.0001). Particle size and zeta potential had
a correlation of 20.43 with a p-value for a test of no association
equal to 0.17. When excluding the outlying particle size (.250),
the correlation was only 20.31 with a p-value of 0.35. Because the
correlation between particle size and zeta potential is relatively
weak and the correlations of both particle size and zeta potential
with cytokines are strong, both particle size and zeta potential
likely have unique effects on the cytokines. We are unable to
ascertain the cause for the deviation from the other five data points
for the single data points marked by asterisks (*) showing an
association between particle size (Figure 5) and Zeta potential
(Figure 6) and cytokine mRNA expression. However, the outlier
(DEP-10x, batch #2, Table 1) in Figure 5 (size) falls outside of the
range of Zeta potential where bioreactivity was observed, while the
outlier (DEP-1x, batch #3, Table 2) in Figure 6 (Zeta potential)
falls outside of the range of sizes where bioreactivity was observed.
Thus it appears that particle size and Zeta potential codetermine
bioreactivity of the cells.
We are not aware of studies that have linked the impact of
particle size and charge changes resulting from DEP collections
and extractions at different times with toxicity and bioreactivity in
cell exposure or animal models. However, a few studies evaluated
the impact of size [29,30] and charge [30,31] of PM on
bioreactivity in in vitro cell model systems. In addition, the source
(coal, DEP, oil) and handling of PM were shown to alter the
bioreactivity in a rat alveolar epithelial cell line (RLE-6TN) [32].
In the present study, using THP-1 cells and primary human
PBMC, we noted significant differences in mRNA expression and
protein production profiles among three batches of DEP and
DEP-Env samples collected at different times and extracted
following different lengths of sample storage. The scope of the
present study is limited to evaluating the impact of particle size and
charge, due to resource constraints. Potential changes in chemical
composition due to differences in collection and extraction times
may also contribute to batch-to-batch differences in bioreactivity.
Indeed, variation in bioreactivity between DEP samples from
different sources depending on their chemical composition has
been reported recently [33]. Preparing DEP samples of most real-
life exposure relevance for in vitro and in vivo experimental studies
has been and will continue to be a challenging issue [34–37].
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